Aug 11, 2020
Researchers Combine Genetic Information with Electronic Medical Records to Pinpoint When Epilepsies Affect Children
Jun 05, 2020
UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
May 12, 2020
Worldwide Epilepsy Markets to 2024
Mar 26, 2020
European Medicines Agency Accepts Arvelle Therapeutics' Marketing Authorization Application for Cenobamate for the Adjunctive Treatment of Focal-Onset Seizures in Adults
Mar 26, 2020
Bio-Pharm Solutions Expands from Epilepsy to Neurodegenerative Diseases Aiming for IPO
Mar 24, 2020
Epilepsy Foundation Appoints Fashion and Beauty Entrepreneur Camila Coelho to Its Board of Directors
Mar 23, 2020
Technological Advancement to Drive Market Players Propel Growth in Epilepsy Therapeutics Market from 2019 to 2027: TMR
Mar 10, 2020
SK life science Receives Schedule V Designation from DEA for XCOPRI® (cenobamate tablets)
Mar 09, 2020
The Global Epilepsy Market, Pipeline and Competition 2020-2030 - Aquestive Therapeutical's AQST-203 Will Be a Blockbuster Drug
Mar 02, 2020
Neurelis Announces Commercial Availability of VALTOCO® (Diazepam Nasal Spray) for Seizure Cluster Rescue
Feb 24, 2020
2020 Pipeline Insight on Refractory Epilepsy - Comprehensive Insights of Present Clinical Development Scenario and Growth Prospects
Feb 18, 2020
Worldwide Epilepsy Pipeline Insights, 2020: Therapeutic Assessment, Product Profiles, Unmet Needs, Key Companies
Feb 10, 2020
Global DEE Market Insights, 2017-2028 - Eisai Pharmaceuticals (Fycompa; Perampanel), Zogenix (Fintepla; ZX008), Takeda/Ovid (Soticlestat; TAK-935/OV935), and Zynerba Pharma (Zygel; ZYN002)
Feb 07, 2020
The SPEAC System's sEMG Seizure Monitoring Results To Be Featured at the American Clinical Neurophysiology Society (ACNS) Annual Meeting
Feb 06, 2020
Year-Long HCP and Patient Education Digital Initiative on Pediatric Epilepsies Launches, with Special Focus on Dravet Syndrome from PlatformQ Health
Feb 04, 2020
Epilepsy Foundation Florida Announces Launch of the Walk to END EPILEPSY® Miami
Jan 27, 2020
Epygenix Therapeutics Successfully Completes EPX-100 Phase I, Placebo-Controlled, Double-Blind, 2-Period Study and Ready to Phase 2 Studies
Jan 13, 2020
Neurelis Announces FDA Approval for Seizure Rescue Treatment VALTOCO® (Diazepam Nasal Spray) that Incorporates the Science of Intravail® for Consistent and Reliable Absorption
Jan 09, 2020
Mercaptor Discoveries Announces Preclinical Program in Epilepsy
Jan 08, 2020
Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy